Seer
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3800 Bridge Pkwy Ste 102, Redwood City, ...Phone Number
(833) 254-7337Website
seer.bioRevenue
$15.2 MillionStock Symbol
SEERIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
2
1
1
1
2
About Seer
Founded in 2017, Seer is a life sciences company focused on capturing deep molecular insights from the proteome to enable novel insights and breakthroughs in the understanding of biology and disease. They are based in Redwood City, California.Explore more
Seer Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Seer your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Seer, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Seer had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Seer
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Seer has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Seer launches new products
Earning: See what the market has to say on Seer recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Seer is spiking on competitors!
Funding: Get notified immidiatlly once Seer has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Seer
Compare insights from companies similar to Seer, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Seer is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Seer is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Seer.
Seer financials insights
Gather financial insights about Seer, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$6M
2018
Series B
$36M
2019
Series C
$17.5M
Series D
$55M
2020
Multiple Rounds
$365M
Seer Tech Stack
A closer look at the technologies used by Seer
See more technologies
Most Recent Scoops
Open Position
Person-Based
Medical Research
Person-Based
Medical Research
Person-Based
Pain Point, Earnings, Finance
Person-Based
Stake & Stock Ownership, Finance
Seer News & Media
Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.
No Stockholder Action Required at This Time No Stockholder Action Required at This TimeSeer Stockholders Vote to Re-Elect All Seven of Seer’s Director Nominees at 2026 Annual Meeting
REDWOOD CITY, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer”) today announced that, based on the preliminary voting results from Seer’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”), Seer stockholders have voted to re-elect all seven of Seer’s director nominees – Omid Farokhzad, M.D.; Meeta Gulyani; Robert Langer, Sc.D.; Terrance McGuire; Dipchand (Deep) Nishar; Isaac Ro; and Nicolas Roelofs, Ph.D. – to Seer’s Board of Directors (the “Board”).Seer Urges Stockholders to Vote “FOR” Seer’s Highly Qualified Director Nominees on the BLUE Proxy Card TODAY
2026 Annual Meeting of Stockholders To Be Held July 28, 2026Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.
REDWOOD CITY, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the Special Committee of Seer’s Board of Directors, consisting of independent directors Meeta Gulyani and Nicolas Roelofs, Ph.D., has thoroughly reviewed and unanimously rejected the unsolicited, non-binding proposal received on July 1, 2026, from Omid Farokhzad, M.D., Seer’s Chair and Chief Executive Officer, to acquire al
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Seer
Sign Up For FreeTo access detailed company insights
Founded in 2017, Seer is a life sciences company focused on capturing deep molecular insights from the proteome to enable novel insights and breakthroughs in the understanding of biology and disease. They are based in Redwood City, California.... Read More
